|
53
|
187
|
8gwfB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwfG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
67
|
405
|
8dv6A |
Zika virus envelope protein structure in complex with a potent human mab |
|
85
|
302
|
7tekA |
Sars-cov-2 3clpro in complex with n-(4-(1h-pyrazol-4-yl)phenyl)-n-(3-chlorobenzyl)-2-(pyridin-3-yl)acetamide |
|
88
|
302
|
7telA |
Sars-cov-2 3clpro in complex with n-(4-(1h-imidazol-4-yl)phenyl)-n-(3-chloro-5-fluorobenzyl)-2-(isoquinolin-4-yl)acetamide |
|
36
|
181
|
8aouA |
Solution nmr structure of full-length nsp1 from sars-cov-2. |
|
89
|
309
|
7wfcA |
X-ray structure of hku1-plp2(cys109ser) catalytic mutant in complex with free ubiquitin |
|
86
|
305
|
7zqvA |
Structure of the sars-cov-2 main protease in complex with ag7404 |
|
77
|
305
|
7qkaA |
Crystal structure of sars-cov-2 main protease in complex with covalently bound gc376 |
|
25
|
94
|
8hdaA |
Crystal structure of ubl1 (residues 18-111) of sars-cov-2 |
|
215
|
620
|
7xd8A |
Crystal structure of dengue virus serotype 2 (denv2) polymerase elongation complex (native form) |
|
44
|
187
|
8gwnB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwgG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
53
|
187
|
8gwiB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwgA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwiG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
184
|
926
|
8gwnA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwiE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
50
|
326
|
7wutA |
Cryoem structure of stable sns1 tetramer |
|
112
|
593
|
8gwnE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwgE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
252
|
680
|
8ejmA |
Crystal structure of human deah-box helicase dhx15 in complex with sugp1 g-patch |
|
58
|
341
|
7wusA |
Cryoem structure of a dimer of loose sns1 tetramer |
|
60
|
341
|
7wurA |
Cryoem structure of sns1 complexed with fab5e3 |
|
21
|
113
|
8gwnG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwiA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
53
|
187
|
8gwgB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
69
|
306
|
8ey2A |
Cryo-em structure of sars-cov-2 main protease c145s in complex with n-terminal peptide |
|
24
|
116
|
8bsdB |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
91
|
301
|
7zv7A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 57 |
|
201
|
926
|
8gwoA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
61
|
306
|
7zb8A |
Crystal structure of sars-cov-2 main protease (mpro) variant k61a at 2.48 a resolution |
|
82
|
305
|
7zv8A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 58 |
|
91
|
301
|
8bsdA |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
85
|
306
|
7zb7A |
Crystal structure of sars-cov-2 main protease (mpro) variant y54f at 1.63 a resolution |
|
63
|
306
|
7zb6A |
Crystal structure of sars-cov-2 main protease (mpro) variant c44s at 2.12 a resolution |
|
131
|
438
|
8ev3D |
Ytm1 associated 60s nascent ribosome (-fkbp39) state 1b |
|
21
|
72
|
8gwoC |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
115
|
439
|
8eupD |
Ytm1 associated 60s nascent ribosome state 1a |
|
51
|
187
|
8gwoB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
21
|
215
|
8etgD |
Fkbp39 associated 60s nascent ribosome state 3 |
|
134
|
438
|
8esrD |
Ytm1 associated nascent 60s ribosome (-fkbp39) state 2 |
|
72
|
306
|
7lcrA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
102
|
593
|
8gwoE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
60
|
439
|
8etiD |
Fkbp39 associated 60s nascent ribosome state 1 |
|
123
|
445
|
8ethD |
Ytm1 associated 60s nascent ribosome state 1b |
|
238
|
927
|
7uo4A |
Sars-cov-2 replication-transcription complex bound to remdesivir triphosphate, in a pre-catalytic state |
|
226
|
926
|
7uo9A |
Sars-cov-2 replication-transcription complex bound to utp, in a pre-catalytic state |
|
281
|
929
|
7uoeA |
Sars-cov-2 replication-transcription complex bound to ctp, in a pre-catalytic state |
|
87
|
301
|
7zv5A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 4 |
